---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-002153"
form_type: "8-K"
ticker: null
cik: "0001825413"
company_name: "Biotech Acquisition Co"
filed_at: "2023-01-11T23:59:59+00:00"
generated_at: "2026-06-20T16:38:40.242608+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Biotech Acquisition receives Nasdaq deficiency notice for missed annual meeting

## Summary
- Received Nasdaq notice on Jan 9, 2023 for failing to hold annual meeting for FY ended Dec 31, 2021.
- Company must submit a plan to regain compliance by Feb 23, 2023.
- If plan accepted, Nasdaq may grant extension until June 29, 2023 to comply.
- Deficiency notice has no immediate effect on listing or trading.
- Company intends to submit a compliance plan within required timeframe.

## SEC filing metadata
- accession: 0001213900-23-002153
- form_type: 8-K
- cik: 0001825413
- company_name: Biotech Acquisition Co
- filed_at: 2023-01-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1825413/000121390023002153/0001213900-23-002153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1825413/000121390023002153/ea171538-8k_biotechacq.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-002153
- JSON: https://secwatch.observer/filing/0001213900-23-002153.json
- Plain text: https://secwatch.observer/filing/0001213900-23-002153.txt

## Key facts
- Listing & Compliance Notices
  Biotech Acquisition Co received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: shareholders
  - Rules: 5620(a)
  source text: January 9, 2023, Biotech Acquisition Company (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5620(a), due to the Company’s failure to hold an annual meeting of shareholders for the fiscal year ended December 31, 2021. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Capital Market. The Notice states that the Com
  evidence_url: https://www.sec.gov/Archives/edgar/data/1825413/000121390023002153/0001213900-23-002153-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.